Impact of duodenal pathology on oral drug bioavailability and disease outcomes in pediatric crohn’s disease

HIGHLIGHTS

• who: Rebecca Casini and collaborators from the Department of Pediatrics, North Shore University Health System, Skokie, IL, USA have published the research work: Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohnu2019s Disease, in the Journal: Pharmaceuticals 2023, 373 of 21/02/2023
• what: The authors aimed to compare disease outcomes in children receiving azathioprine for the treatment of Crohn`s disease with (DP) and without (NDP) duodenal at diagnosis. The study was approved by the CMH IRB and conducted in accordance 7 of 9 with the ethical standards of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.